Research Article Volume 8 Issue 10 - 2025

Mothers' Knowledge and Perception about Vaccines: A Study of Immunization Decision-Making amongst Mothers in the Ukpenu Community, Edo State

Oshikhamele Zurietu Beauty1*, Anwuli Emina1, Munge F Mary1, Adoghe Blessing Isoken2, Olawale Abosede Yetunde3, Iyore Osasu Precious2, Emeka Nnenna N4,5, Nwankwo Eyiuche Esther2 and Obuye Ijeoma Victoria2

1Department of Nursing Science, Faculty of Allied Health Sciences, Benson Idahosa University, Benin City, Edo State, Nigeria

2Department of Nursing Science, Faculty of Nursing, Edo State College of Nursing Sciences, K6, Sapele Road by Godwin Abbe Junction, Benin City, Nigeria

3Achievers College of Nursing Sciences, Akure, Ondo State, Nigeria

4Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Medicine, Alex Ekwueme Federal University Ndufu-Alike Ikwo Ebonyi State Nigeria

5Department of Community Medicine, Faculty of Clinical Medicine ,Alex Ekwueme Federal University Teaching Hospital Abakaliki, Ebonyi State Nigeria

*Corresponding Author: Oshikhamele Zurietu Beauty, Department of Nursing Science, Faculty of Allied Health Sciences, Benson Idahosa University, Benin City, Edo State, Nigeria.
Received: September 23, 2025; Published: October 10, 2025



Background: Maternal knowledge and attitudes toward immunization are key factors influencing vaccine uptake and child health outcomes. Understanding these factors is essential to improving immunization coverage in local communities.

Objective: To assess the knowledge and perception of mothers with children under five years of age toward routine childhood immunization in the Ukpenu community, Esan West Local Government Area, Edo State, Nigeria.

Methods: A descriptive, cross-sectional study design was adopted using a non-experimental approach. A total of 275 mothers were selected through a convenience sampling technique. Data were collected using a structured questionnaire consisting of 21 close-ended questions, divided into three sections. Descriptive statistics, including frequency tables and percentages, were used for data analysis.

Results: Out of the 275 participants, 95.6% reported having heard of immunization, while 4.4% had not. In terms of attitude, 92.6% demonstrated a positive attitude toward immunization, whereas 7.4% showed a negative attitude. The findings indicate that the majority of mothers had good knowledge and a favorable attitude regarding childhood immunization.

Conclusion: Most mothers in the Ukpenu community possess adequate knowledge and positive attitudes toward immunization. To further improve immunization uptake, the study recommends that the Edo State Ministry of Health enhance health education campaigns targeting mothers. These should include vaccination booklets detailing immunization benefits, schedules, card importance, and management of common side effects. Routine education on immunization should also be integrated into antenatal and postnatal care services.

 Keywords: Immunization; Knowledge; Attitude; Ukpenu Community

  1. MI Fortmann., et al. “Immunization of preterm infants: current evidence and future strategies to individualized approaches”. Seminars in Immunopathology 6 (2022): 767-784.
  2. WH Chen., et al. "Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights”. Expert Review of Vaccines 10 (2022): 1405-1417.
  3. R Palich., et al. “Kaposi's Sarcoma in virally suppressed people living with HIV: An emerging condition”. Cancers (Basel)22 (2021): 5702.
  4. A Vora., et al. “Vaccination in older adults: an underutilized opportunity to promote healthy aging in India”. Drugs and Aging6 (2021): 469-479.
  5. A Vaid., et al. “Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective”. Human Vaccines and Immunotherapeutics 2 (2023): 2224186.
  6. M Shen., et al. “The impact of supplementary immunization activities on measles transmission dynamics and implications for measles elimination goals: A mathematical modelling study”. Journal of Theoretical Biology 551-552 (2022): 111242.
  7. QH Liu., et al. “Model-based evaluation of alternative reactive class closure strategies against COVID-19”. Nature Communications 1 (2022): 322.
  8. "Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021”. Lancet10469 (2024): 2341-2370.
  9. S Bertagnolio., et al. “WHO global research priorities for antimicrobial resistance in human health”. Lancet Microbe 11 (2024): 100902.
  10. "Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023”. Lancet10500 (2025): 235-260.
  11. OA Bolarinwa., et al. “Barriers and enablers to childhood immunization in high zero-dose burden communities in Kano and Lagos states, Nigeria”. Vaccine 64 (2025): 127754.
  12. ND Johansen., et al. “Electronic nudges to increase influenza vaccination in patients with chronic diseases: a randomized clinical trial”. Journal of the American Medical Association 22 (2024): 1900-1911.
  13. R Moirangthem and Y Bar-On. "Passive immunization in the prevention and treatment of viral infections”. European Journal of Immunology 5 (2025): e202451606.
  14. C Angulo., et al. “Plant- and microalgae-made fish vaccines”. Fish and Shellfish Immunology 165 (2025): 110539.
  15. YD Tang., et al "Viral live-attenuated vaccines (LAVs): Past and future directions”. Advanced Science (Weinh)3 (2025): e2407241.
  16. EB Walter., et al. “Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial”. JAMA Network Open 11 (2024): e2443166.
  17. "Diphtheria-Tetanus-Pertussis Vaccines". In Drugs and Lactation Database (LactMed®). Bethesda (MD): National Institute of Child Health and Human Development (2006).
  18. Y Deng., et al. “Tamibarotene-loaded nanoemulsion incorporating toll-like receptor 2/6 agonist as an intramuscular adjuvant system enhances gastrointestinal mucosal immunity”. ACS Nano20 (2025): 19149-19167.
  19. P Kardos., et al. “Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations”. Human Vaccines and Immunotherapeutics 1 (2024): 2324547.
  20. JPA Ioannidis., et al. "Global estimates of lives and life-years saved by COVID-19 vaccination during 2020-2024”. JAMA Health Forum7 (2025): e252223.
  21. H Razzaghi., et al. “Maternal respiratory syncytial virus vaccination and receipt of respiratory syncytial virus antibody (Nirsevimab) by infants aged <8 months - United States, April 2024”. Morbidity and Mortality Weekly Report 38 (2024): 837-843.
  22. R Zhu., et al. “ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion”. Cell Metabolism 2 (2025): 361-376.e7.
  23. L Zhang., et al. "Knowledge, attitude, and practice toward vocal cord polyp among patients: a cross-sectional study”. Journal of Voice (2024).
  24. Z Jiang., et al. "Impact of knowledge-attitude-practice model nursing based on reproductive health education on patients with reproductive tract infections”. European Journal of Obstetrics and Gynecology and Reproductive Biology 313 (2025): 114593.
  25. W Bleidorn., et al. "Big Five personality traits and vaccination: A systematic review and meta-analysis”. Health Psychology 1 (2025): 44-56.
  26. Y Castelfranchi., et al. "Vaccines in Brazil in the pandemic: a study of public perception". Ciência & Saúde Coletiva 4 (2025): e16802023.
  27. Y Mohammed., et al. “Exploring the landscape of routine immunization in Nigeria: A scoping review of barriers and facilitators”. Vaccine X 20 (2024): 100563.
  28. L Boonstoppel., et al. “Cost of integrated immunization campaigns in Nigeria and Sierra Leone: bottom-up costing studies”. BMC Health Services Research 1 (2024): 1334.
  29. BB Afolabi., et al. “Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial”. Lancet Global Health 10 (2024): e1649-e1659.
  30. R Sato. "Trends of the second measles vaccine (MCV2) over time after its launch as part of routine immunization in Nigeria: a brief research report”. Frontiers in Public Health 12 (2024): 1392996.
  31. SA Omoleke and LC de Kiev. "An evaluation of the surveillance system for monitoring and reporting adverse events following immunization in Kebbi State, Northern Nigeria: a mixed method approach”. BMC Public Health1 (2024): 2906.
  32. F Tian., et al. "Sample-size determination for decentralized clinical trials”. International Journal of Epidemiology 3 (2025).

Oshikhamele Zurietu Beauty., et al. “Mothers' Knowledge and Perception about Vaccines: A Study of Immunization Decision-Making amongst Mothers in the Ukpenu Community, Edo State”. EC Clinical and Medical Case Reports  8.10 (2025): 01-15.